id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-266135-jbc9nml0	Princiotta Cariddi, Lucia	Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient	2020-06-24		.txt	text/plain	1141	78	41	title: Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2. Brain CT and CTA were consistent with hemorrhagic Posterior Reversible Encephalopathy Syndrome (PRES; Fig. 1a, b) . Posterior reversible encephalopathy syndrome in infection, sepsis, and shock Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection	./cache/cord-266135-jbc9nml0.txt	./txt/cord-266135-jbc9nml0.txt